Trends in Healthcare Resource Use Preceding Diagnosis of Alzheimer's Disease Dementia

por Abbass, Ibrahim M., Choi, Dae, Wallick, Christopher, Assunção, Sheila Seleri
Publicado 2023

Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease

por Assunção, Sheila Seleri, Sperling, Reisa A., Ritchie, Craig, Kerwin, Diana R., Aisen, Paul S., Lansdall, Claire, Atri, Alireza, Cummings, Jeffrey
Publicado 2022

Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease

por Bateman, Randall J., Cummings, Jeffrey, Schobel, Scott, Salloway, Stephen, Vellas, Bruno, Boada, Mercè, Black, Sandra E., Blennow, Kaj, Fontoura, Paulo, Klein, Gregory, Assunção, Sheila Seleri, Smith, Janice, Doody, Rachelle S.
Publicado 2022